These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age. Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663 [TBL] [Abstract][Full Text] [Related]
3. Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus. Soto N; Iñiguez G; López P; Larenas G; Mujica V; Rey RA; Codner E Hum Reprod; 2009 Nov; 24(11):2838-44. PubMed ID: 19643804 [TBL] [Abstract][Full Text] [Related]
4. A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles. Robertson DM; Hale GE; Fraser IS; Hughes CL; Burger HG Menopause; 2008; 15(6):1139-44. PubMed ID: 18779761 [TBL] [Abstract][Full Text] [Related]
5. Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age. Knauff EA; Richardus R; Eijkemans MJ; Broekmans FJ; de Jong FJ; Fauser BC; Bosch AM Reprod Sci; 2007 Dec; 14(8):780-5. PubMed ID: 18089596 [TBL] [Abstract][Full Text] [Related]
6. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Burger HG; Hale GE; Robertson DM; Dennerstein L Hum Reprod Update; 2007; 13(6):559-65. PubMed ID: 17630397 [TBL] [Abstract][Full Text] [Related]
7. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. van Rooij IA; Broekmans FJ; Scheffer GJ; Looman CW; Habbema JD; de Jong FH; Fauser BJ; Themmen AP; te Velde ER Fertil Steril; 2005 Apr; 83(4):979-87. PubMed ID: 15820810 [TBL] [Abstract][Full Text] [Related]
8. Possibilities and limits of ovarian reserve testing in ART. La Marca A; Argento C; Sighinolfi G; Grisendi V; Carbone M; D'Ippolito G; Artenisio AC; Stabile G; Volpe A Curr Pharm Biotechnol; 2012 Mar; 13(3):398-408. PubMed ID: 21657996 [TBL] [Abstract][Full Text] [Related]
9. Inhibin A and B as markers of menopause: a five-year prospective longitudinal study of hormonal changes during the menopausal transition. Overlie I; Mørkrid L; Andersson AM; Skakkebaek NE; Moen MH; Holte A Acta Obstet Gynecol Scand; 2005 Mar; 84(3):281-5. PubMed ID: 15715537 [TBL] [Abstract][Full Text] [Related]
10. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Gnoth C; Schuring AN; Friol K; Tigges J; Mallmann P; Godehardt E Hum Reprod; 2008 Jun; 23(6):1359-65. PubMed ID: 18387961 [TBL] [Abstract][Full Text] [Related]
11. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age. Steiner AZ; Pritchard D; Stanczyk FZ; Kesner JS; Meadows JW; Herring AH; Baird DD JAMA; 2017 Oct; 318(14):1367-1376. PubMed ID: 29049585 [TBL] [Abstract][Full Text] [Related]
12. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition. Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS Menopause; 2009; 16(1):50-9. PubMed ID: 18978637 [TBL] [Abstract][Full Text] [Related]
13. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213 [TBL] [Abstract][Full Text] [Related]
14. Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction. Al-Azemi M; Killick SR; Duffy S; Pye C; Refaat B; Hill N; Ledger W Hum Reprod; 2011 Feb; 26(2):414-22. PubMed ID: 21147822 [TBL] [Abstract][Full Text] [Related]
15. Measuring ovarian function in young cancer survivors. Su HI Minerva Endocrinol; 2010 Dec; 35(4):259-70. PubMed ID: 21178920 [TBL] [Abstract][Full Text] [Related]
16. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. Sowers MR; Eyvazzadeh AD; McConnell D; Yosef M; Jannausch ML; Zhang D; Harlow S; Randolph JF J Clin Endocrinol Metab; 2008 Sep; 93(9):3478-83. PubMed ID: 18593767 [TBL] [Abstract][Full Text] [Related]
17. Detection of serum antimüllerian hormone in women approaching menopause using sensitive antimüllerian hormone enzyme-linked immunosorbent assays. Robertson DM; Kumar A; Kalra B; Shah S; Pruysers E; Vanden Brink H; Chizen D; Visser JA; Themmen AP; Baerwald A Menopause; 2014 Dec; 21(12):1277-86. PubMed ID: 24781853 [TBL] [Abstract][Full Text] [Related]